Diagnostic Digest
-
July 13, 2026
Cyclosporiasis: What You Need to Know About the Emerging Parasitic Infection
Monitor the 2026 rise in Cyclospora infections, explore cyclosporiasis symptoms, and learn how BIOFIRE GI Panels support rapid detection and surveillance.
-
July 09, 2026
Diagnose Confidently, Deescalate Earlier: The Value of Multiplex PCR for ED Respiratory Cases
When an otherwise healthy patient presents to the emergency department (ED) with mild respiratory symptoms, the risks associated with empiric therapy is generally low. Immunocompromised patients, on the other hand, don’t have the luxury of uncertainty. For these at-risk individuals, a missed diagnosis or prolonged exposure to empiric antimicrobials may worsen outcomes.
-
July 07, 2026
Diagnostic Stewardship & Molecular Assays: A Laboratorian’s Primer
Diagnostic stewardship programs optimize laboratory testing, improve patient care, reduce unnecessary testing, and support value-based healthcare goals.
-
June 25, 2026
Key Takeaways: Advancing Antimicrobial Stewardship in Outpatient Care
Outpatient antimicrobial stewardship is a shared responsibility across healthcare disciplines. Whether you are a clinician, microbiologist, pharmacist, nurse, infection preventionist, or public health professional, small changes can have a meaningful impact.
-
June 04, 2026
Local Health Monitor: Infectious Disease Insights for Smarter Healthcare Decisions
The Local Health Monitor helps eliminate that uncertainty by delivering a comprehensive, data-driven view of infectious disease activity at the local level. Powered by the latest CDC data, this interactive dashboard helps healthcare teams anticipate patient volumes, optimize testing readiness, and respond with confidence.
-
May 07, 2026
The Value of Preventing Acute Kidney Injury for Cardiovascular Patients
This article summarizes the findings of our “The Value of Preventing Acute Kidney Injury” Dossier, including the current burden of AKI for hospitals, where current risk assessment practices fall short, and how VIDAS® NEPHROCHECK® [TIMP-2 · IGFBP-7] from bioMérieux is designed to fill in the gaps.
-
April 30, 2026
The Evolution of MALDI‑TOF in the Clinical Microbiology Laboratory
The introduction of matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry (MALDI‑TOF MS) marked a fundamental shift in how laboratories identify microorganisms, transforming workflows that once emphasized stepwise exclusion into ones driven by rapid, data‑rich pattern recognition.
-
April 16, 2026
Lab Professionals Celebrating Lab Professionals: A Look Behind the bioMérieux Bench
Behind every diagnosis is a lab professional who made it possible, yet their expertise and dedication rarely get the recognition they deserve. And with the ever-evolving healthcare landscape, just trying to keep up can feel like a challenge.
-
April 15, 2026
Why One Health Collaboration Is Essential for Tackling AMR
The AMR Pathways webinar series raises awareness of antimicrobial resistance (AMR) as an urgent global health challenge and highlights actions to reduce its burden. Through expert insights, real-world case studies, and practical strategies, the series equips participants to advance antimicrobial stewardship (AMS), drive meaningful change, and navigate evolving policy and diagnostic landscapes. -
March 19, 2026
Equity, Accuracy, and Stewardship: Rethinking Vaginitis Diagnosis for Women Everywhere
Vaginitis remains a leading cause of gynecologic-related primary care visits in the United States, yet the approach to diagnosis and treatment continues to present significant challenges for clinicians and public health professionals. Recent studies underscore persistent gaps in diagnostic testing and highlight the consequences for antimicrobial stewardship and patient outcomes. -
February 19, 2026
Decrease Antibiotic and Steroid Prescribing While Increasing Clinician Confidence: The Strong Case for a Novel Rapid Multiplex PCR in Urgent Care
Combining an antibiotic stewardship program (ASP) with a 15-pathogen viral panel to reduce inappropriate antibiotic prescribing.
-
February 11, 2026
Is Flu/COVID/RSV Testing Enough? A Comparison of Multiplex Respiratory Testing
This articles features a comparison of the performance of BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel, Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV, and Cobas® SARS-CoV-2 & Influenza A/B assay for detection of respiratory viruses.